Cet anticorps Lapin Polyclonal détecte spécifiquement GRIN2D dans WB et ELISA. Il présente une réactivité avec des échantillons de Humain, Rat et Souris.
GRIN2D
Reactivité: Humain, Rat, Souris
ELISA, IHC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:10000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Glutamate [NMDA] receptor subunit epsilon-4, EB11, N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2DGRIN2D (Glutamate Ionotropic Receptor NMDA Type Subunit 2D) is a Protein Coding gene. Diseases associated with GRIN2D include Epileptic Encephalopathy, Early Infantile, 46 and Undetermined Early-Onset Epileptic Encephalopathy. Among its related pathways are Calcium signaling pathway and RET signaling.